Despite the extensive research into stem cells, the biotech industry has hitherto been unable to capitalise on the vast therapeutic potential of these technologies. Now they are being surpassed by more advanced forms of genetic manipulation whereby human genes, cells, and even entire ...
Please Login to read the full article.
